What does proceeds from issuance of warrants mean?

This represents the cash inflows received by the company from the issuance of warrants, which are financial instruments granting the holder the right to purchase company stock at a specified price. It serves as a source of external capital and reflects investor confidence in the company's future equity value. This metric is critical for assessing potential future dilution and capital structure changes.

CytomX Therapeutics CTMX Proceeds From Issuance Of Warrants

Proceeds From Issuance Of Warrants at other companies

Replimune GroupREPL

$0-100%

Aura Biosciences, Inc.AURA

$3.54M—

CytomX TherapeuticsCTMX

$5.86M—

LCI IndustriesLCII

$0-100%

Quantum Computing Inc.QUBT

$1K-99.8%

Taysha Gene Therapies, Inc.TSHA

$56.25K—

Other financials

Income statement

See full

Revenue$10.3M-79.9%

Operating income-$19.7M-187%

Net income-$18.2M-178%

EPS (diluted)-$0.10-137%

Balance sheet

See full

Cash & equivalents$28.8M-39.4%

Total debt$2.9M-65.0%

Total equity$319.9M+1,177%

Total assets$359.4M+265%

Cash flow

See full

Operating cash flow-$25.5M-21.4%

CapEx--100%

Free cash flow-$25.5M-20.7%

Valuation

See full

Market cap$711.89M+94.8%

Enterprise value$685.92M+110%

P/S20×+17.6×

Profitability

See full

Operating margin-181.9%-206pp

Net margin-166.4%-195pp

FCF margin-225.6%-334pp

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×-0.3×

Current ratio10.4×+8.7×

Where this comes from

Reported directly by CytomX Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfWarrants.

The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's proceeds from issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CytomX Therapeutics's proceeds from issuance of warrants?: CytomX Therapeutics (CTMX) reported proceeds from issuance of warrants of $5.86M in Q1 2026.
What does proceeds from issuance of warrants mean?: This represents the cash inflows received by the company from the issuance of warrants, which are financial instruments granting the holder the right to purchase company stock at a specified price. It serves as a source of external capital and reflects investor confidence in the company's future equity value. This metric is critical for assessing potential future dilution and capital structure changes.